See more : Almonty Industries Inc. (AII.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhejiang Shouxiangu Pharmaceutical Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Xiamen Bank Co., Ltd. (601187.SS) Income Statement Analysis – Financial Results
- New Wave Group AB (publ) (0KIZ.L) Income Statement Analysis – Financial Results
- Landis+Gyr Group AG (LGYRF) Income Statement Analysis – Financial Results
- Future Science Holdings Inc. (FUTS) Income Statement Analysis – Financial Results
- Furukawa Electric Co., Ltd. (5801.T) Income Statement Analysis – Financial Results
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)
About Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. researches, develops, and sells Chinese medicine products. It offers ganoderma lucidum spore powder, dendrobium officinale, crocus sativus, and other health products. The company was founded in 1997 and is based in Jinhua, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 784.35M | 829.07M | 767.14M | 636.05M | 546.76M | 511.45M | 369.96M | 314.88M | 301.91M | 301.59M | 253.03M | 177.75M |
| Cost of Revenue | 135.53M | 129.21M | 126.37M | 105.67M | 85.41M | 72.06M | 50.93M | 47.58M | 57.47M | 82.15M | 87.86M | 76.38M |
| Gross Profit | 648.82M | 699.86M | 640.76M | 530.38M | 461.35M | 439.39M | 319.03M | 267.30M | 244.45M | 219.44M | 165.17M | 101.37M |
| Gross Profit Ratio | 82.72% | 84.42% | 83.53% | 83.39% | 84.38% | 85.91% | 86.23% | 84.89% | 80.97% | 72.76% | 65.28% | 57.03% |
| Research & Development | 49.68M | 47.82M | 50.82M | 48.49M | 39.42M | 33.67M | 20.97M | 17.81M | 17.95M | 20.55M | 12.70M | 9.00M |
| General & Administrative | 43.93M | 37.19M | 35.67M | 44.99M | 58.98M | 53.09M | 18.39M | 12.44M | 12.01M | 13.91M | 33.11M | 23.37M |
| Selling & Marketing | 316.79M | 319.37M | 319.76M | 264.02M | 233.65M | 236.50M | 178.56M | 138.79M | 128.07M | 103.84M | 72.72M | 44.73M |
| SG&A | 360.73M | 356.57M | 355.43M | 309.01M | 292.63M | 289.59M | 196.95M | 151.24M | 140.08M | 117.75M | 105.83M | 68.11M |
| Other Expenses | -58.16M | 28.12M | 34.55M | 16.68M | 15.32M | -216.80K | -2.05M | 9.94M | 5.26M | 3.23M | 2.37M | 4.10M |
| Operating Expenses | 394.10M | 432.51M | 440.81M | 374.18M | 347.37M | 339.96M | 233.31M | 191.37M | 181.08M | 155.42M | 107.37M | 68.96M |
| Cost & Expenses | 529.62M | 561.71M | 567.18M | 479.85M | 432.77M | 412.02M | 284.24M | 238.94M | 238.55M | 237.58M | 195.24M | 145.34M |
| Interest Income | 48.09M | 25.45M | 24.16M | 11.51M | 3.33M | 1.90M | 600.48K | 24.62K | 125.91K | 196.59K | 0.00 | 0.00 |
| Interest Expense | 25.05M | 13.03M | 10.17M | 11.72M | 978.99K | 969.11K | 1.91M | 6.85M | 7.97M | 1.61M | 1.78M | 1.63M |
| Depreciation & Amortization | 99.99M | 81.08M | 65.83M | 54.70M | 49.13M | 47.07M | 39.88M | 114.07M | 35.42M | 20.84M | 8.32M | 1.40M |
| EBITDA | 379.58M | 372.71M | 278.36M | 220.73M | 175.67M | 158.29M | 131.16M | 202.54M | 98.54M | 87.55M | 60.98M | 33.67M |
| EBITDA Ratio | 48.39% | 43.08% | 34.69% | 32.93% | 30.65% | 29.64% | 34.46% | 40.33% | 35.22% | 29.64% | 24.10% | 18.13% |
| Operating Income | 254.72M | 280.88M | 207.15M | 158.90M | 127.77M | 110.30M | 90.84M | 71.01M | 57.50M | 66.45M | 52.65M | 30.83M |
| Operating Income Ratio | 32.48% | 33.88% | 27.00% | 24.98% | 23.37% | 21.57% | 24.55% | 22.55% | 19.04% | 22.03% | 20.81% | 17.34% |
| Total Other Income/Expenses | 188.56K | -2.91M | -6.09M | -5.20M | -2.78M | -216.80K | -2.05M | 9.94M | 5.13M | 3.08M | 2.37M | 2.49M |
| Income Before Tax | 254.91M | 277.97M | 201.06M | 153.70M | 124.99M | 110.09M | 88.79M | 80.93M | 62.62M | 69.53M | 55.02M | 34.90M |
| Income Before Tax Ratio | 32.50% | 33.53% | 26.21% | 24.17% | 22.86% | 21.52% | 24.00% | 25.70% | 20.74% | 23.05% | 21.74% | 19.63% |
| Income Tax Expense | 430.87K | 452.57K | 749.29K | 1.99M | 1.10M | 2.44M | -88.85K | -50.62K | -21.14K | 278.26K | 971.62K | 874.82K |
| Net Income | 254.48M | 277.78M | 200.83M | 151.71M | 123.90M | 107.65M | 88.88M | 80.98M | 62.64M | 69.25M | 54.05M | 34.02M |
| Net Income Ratio | 32.44% | 33.51% | 26.18% | 23.85% | 22.66% | 21.05% | 24.02% | 25.72% | 20.75% | 22.96% | 21.36% | 19.14% |
| EPS | 1.30 | 1.44 | 1.04 | 0.82 | 0.68 | 0.59 | 0.55 | 0.59 | 0.46 | 0.51 | 0.40 | 0.32 |
| EPS Diluted | 1.30 | 1.44 | 1.04 | 0.82 | 0.68 | 0.58 | 0.55 | 0.59 | 0.46 | 0.51 | 0.40 | 0.32 |
| Weighted Avg Shares Out | 195.75M | 192.54M | 193.59M | 184.32M | 183.03M | 181.74M | 162.72M | 136.72M | 135.73M | 136.40M | 104.93M | 104.93M |
| Weighted Avg Shares Out (Dil) | 195.75M | 192.54M | 193.59M | 184.32M | 183.03M | 184.14M | 162.74M | 136.72M | 135.73M | 136.40M | 104.93M | 104.93M |
No news found for: 603896.SS
Source: https://incomestatements.info
Category: Stock Reports